main
Aikaterini Angelopoulou
Welcome to my homepage

cvBrief resume

Name: Katerina Angelopoulou

Address: Laboratory of Biochemistry and Toxicology, School of Veterinary Medicine, Aristotle University of Thessaloniki, Greece 54124

Phone: +302310 999825
e-mail: kangelop@vet.auth.gr

Education
1987-1992 B.Sc. Department of Chemistry, University of Athens, Greece

1992-1997 Ph.D. Department of Clinical Biochemistry, University of Toronto, Canada


Post-doctoral training
1997-1998 Department of Pathology and Laboratory Medicine,
Mount Sinai Hospital, Toronto, Canada

1999 Department of Molecular Genetics, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus

2000-2001 Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Greece


Academic appointments/Professional experience
2001-2008 Lecturer Laboratory of Biochemistry and Toxicology, School of Veterinary Medicine, Aristotle University of Thessaloniki

2008 -
Assistant Professor
Laboratory of Biochemistry and Toxicology, School of Veterinary Medicine, Aristotle University of Thessaloniki


Principal scientific activities and responsibilities of the position currently held

• Teaching

- Chemistry
- Biochemistry
- Molecular Biology
- Molecular Biology Techniques and their Applications in Veterinary Medicine

• Research mainly focused on

- the study of the expression of cancer-related genes in animal models of carcinogenesis
- the use of molecular biology techniques in the diagnosis of genetic and infectious diseases of
domestic and reproductive animals
Professional memberships
Hellenic Society of Biochemistry and Molecular Biology
Hellenic Society of Clinical Chemistry – Clinical Biochemistry


Ph.D. advisory committees
2005 - 2010 Member, M. Zavlaris, DVM
2006 - 2012 Member, E. Gallides, DVM
2007 - 2013 Member, M. Doulberis, DVM
2013 - Member, I. Margaritis, DVM


Reviewer in scientific journals
International Journal of Cancer
British Journal of Cancer
Tumor Biology
Clinical Chemistry
Cancer Letters
The Veterinary Journal
Journal of Dairy Science
BMC Veterinary Research
Viruses


Publications
1. Angelopoulou K, Diamandis EP (1993). Autoantibodies against the p53 tumor suppressor gene product quantified in cancer patient serum with time-resolved immunofluorometry. Cancer J 6: 315-321.
2. Angelopoulou K, Diamandis EP, Sutherland D, Kellen JA, Bunting PS (1994). Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers. Int J Cancer 58: 480-487.
3. Levesque MA, D’Costa M, Angelopoulou K, Diamandis EP (1995). Time-resolved immunofluorometric assay of p53 protein. Clin Chem 41: 1720-1729.
4. Angelopoulou K, Rosen B, Stratis M, Yu H, Solomou M, Diamandis EP (1996). Circulating antibodies against p53 protein in ovarian cancer: Correlation with clinicopathological features and survival. Cancer 77: 2146-2152.
5. Angelopoulou Κ, Stratis M, Diamandis EP (1997). Humoral immune response against the p53 tumor suppressor gene product in patients with colorectal carcinoma. Int J Cancer 70: 46-51.
6. Angelopoulou K, Diamandis EP (1997). Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancer. Eur J Cancer 33: 115-121.
7. Zarghami N, Levesque MA, D’Costa M, Angelopoulou K, Diamandis EP (1997). Frequency of prostate specific antigen mRNA expression in lung tumors. Am J Clin Pathol 108: 184-190.
8. Angelopoulou K, Diamandis EP (1998). Identification of deletions and insertions in the p53 gene using muliplex PCR and high resolution fragment analysis: application to breast and ovarian tumors. J Clin Lab Anal 12: 250-256.
9. Αngelopoulou K, Levesque MA, Katsaros D, Shipman R, Diamandis EP (1998). Exon 5 of the p53 gene is a target for deletions in ovarian cancer. Clin Chem 44: 72-77.
10. Bharaj BS, Angelopoulou K, Diamandis EP (1998). Rapid sequencing of the p53 gene with a new automated DNA sequencer. Clin Chem 44: 1397-1403.
11. Lianidou ES, Angelopoulou K, Katsaros D, Durando A, Massdario M, Diamandis EP (1998). Fragment analysis of the p53 gene in ovarian tumors. Clin Biochem 31: 551-553.
12. Angelopoulou K, Prody C, Diamandis EP (1998). A candidate new gene on human chromosome 5q12 contains a motif that is found in transcriptional co-activators. Clin Biochem 31: 687-688.
13. Lianidou ES, Levesque MA, Katsaros D, Angelopoulou K, Yu H, Genta F, Arisio R, Massorbio M, Bharaj B, Diamandis EP (1999). Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma. Anticancer Res 19: 749-756.
14. Angelopoulou K, Borchert G, Lianidou ES, Melegos DN, Lilja H, Diamandis EP (1999). Characterization of the BRCA1-like immunoreactivity of human seminal plasma. Urology 54: 753-762.
15. Angelopoulou K, Yu H, Bharaj BS, Giai M, Diamandis EP (2000). p53 gene mutation, tumor p53 protein overexpression and serum p53 autoantibody generation in patients with breast cancer. Clin Biochem 33: 53-62.
16. Angelopoulou K, Nicolaides A, Deltas CC (2000). Prevalence of genetic mutations that predispose to thrombophilia in a Greek-Cypriot population. Clin Appl Thromb/Hemost 6: 104-107.
17. Stathopoulou A, Angelopoulou K, Georgoulias V and Lianidou ES (2001). Quantitative RT-PCR luminometric hybridization assay with an RNA-internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer. Clin Biochem 34: 651-659.
18. Angelopoulou K, Spiropoulou T, Stathopoulou A, Dimitroulopoulos D, Malamos N, Georgoulias V, Paraskevas E and Lianidou ES (2003). Development of a highly sensitive RT-PCR luminometric hybridization assay for human telomerase reverse transcriptase beta-plus transcript. Anticancer Res 23: 4821-4830.
19. Spiropoulou A, Ferekidou E, Angelopoulou K, Stathopoulou A, Talieri M, Lianidou ES (2004). Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase beta plus transcript in MCF-7 cells. Clin Biochem 37: 299-304.
20. Karanikolaou K, Angelopoulou K, Papanastasopoulou M, Koumpati-Artopiou M, Papadopoulos O, Koptopoulos G (2005). Detection of small ruminant lentiviruses by PCR and serology tests in field samples of animals from Greece. Small Rum Res 58: 181-187.
21. Angelopoulou K, Karanikolaou K, Papanastasopoulou M, Koumpati-Artopiou M, Vlemmas I, Papadopoulos O, Koptopoulos G (2005). First partial characterisation of small ruminant lentiviruses from Greece. Vet Microbiol 109: 1-9.
22. Angelopoulou K, Brellou GD, Greenland T, Vlemmas I (2006). A novel deletion in the LTR region of a Greek small ruminant lentivirus may be associated with low pathogenicity. Virus Res 118: 178-184.
23. Angelopoulou K, Brellou GD, Vlemmas I (2006). Detection of maedi-visna virus in the kidneys of naturally infected sheep. J Comp Pathol 134: 329-335.
24. Brellou GD, Angelopoulou K, Poutahidis T, Vlemmas I (2007). Detection of maedi-visna virus in the liver and heart of naturally infected sheep. J Comp Pathol 136: 27-35.
25. Angelopoulou K, Poutahidis T, Brellou GD, Greenland T, Vlemmas I (2008). A deletion in the R region of SRLV long terminal repeats is associated with decreased pathology in the lung. Vet J 175: 346-355.
26. Poutahidis T, Doulberis M, Karamanavi E, Angelopoulou K, Koutinas CK, Papazoglou LG (2008). Primary gastric choriocarcinoma in a dog. J Comp Pathol 139: 146-150.
27. Angelopoulou K, Zavlaris M, Papaioannou N, Vlemmas I (2008). Canis familiaris telomerase reverse transcriptase undergoes alternative splicing. Mamm Genome 19: 647-653.
28. Oikonomou G, Angelopoulou K, Arsenos G, Zygoyiannis D, Banos G (2009). The effects of polymorphisms in the DGAT1, leptin and growth hormone receptor gene loci on body energy, blood metabolic and reproductive traits of Holstein cows. Anim Genet 40: 10-17.
29. Poutahidis T, Angelopoulou K, Karamanavi E, Polizopoulou ZS, Doulberis M, Latsari M, Kaldrymidou E (2009). Mycotic encephalitis and nephritis in a dog due to infection with Cladosporium cladosporioides. J Comp Pathol 140: 59-63.
30. Zavlaris M, Angelopoulou K, Vlemmas I, Papaioannou N (2009). Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy? Anticancer Res 29: 319-325.
31. Angelopoulou K, Prassas I, Yousef GM (2009). The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer. Gene 446: 68-74.
32. Angelopoulou K, Karagiannis GS. The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer. Mammalian Genome 20: 758-767, 2009.
33. Angelopoulou K, Karagiannis GS. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer. Mammalian Genome 21: 516-524, 2010.
34. Kouti V, Papazoglou L, Flaskos J, Angelopoulou K, Karkavelas G, Rallis T. Ursodeoxycholic acid promotes intestinal adaptation in a cat model of short bowel syndrome. Fundamental and Clinical Pharmacology 25: 734-742, 2011.

GenBank submissions
1. AF038385
Homo sapiens chromosome 5 external transcribed spacer, complete sequence
2. U90205
HSU90205 Human lung carcinoma homo sapiens cDNA, mRNA sequence
3. DQ494804
Chlamydophila abortus strain FAS small cysteine-rich outer membrane
lipoprotein (omcA) gene, complete cds
4. DQ494805
Chlamydophila abortus strain FAG small cysteine-rich outer membrane lipoprotein (omcA) gene, complete cds
5. DQ494806
Chlamydophila abortus strain VPG small cysteine-rich outer membrane lipoprotein (omcA) gene, complete cds
6. DQ494807
Chlamydophila abortus strain LLG small cysteine-rich outer membrane lipoprotein (omcA) gene, complete cds
7. DQ494808
Chlamydophila abortus strain POS small cysteine-rich outer membrane lipoprotein (omcA) gene, complete cds
8. DQ494809
Chlamydophila abortus strain FAS large cysteine-rich 60 kDa membrane complex protein (omcB) gene, partial cds
9. DQ494810
Chlamydophila abortus strain FAG large cysteine-rich 60 kDa membrane complex protein (omcB) gene, partial cds
10. DQ494811
Chlamydophila abortus strain VPG large cysteine-rich 60 kDa membrane complex protein (omcB) gene, partial cds
11. DQ494812
Chlamydophila abortus strain LLG large cysteine-rich 60 kDa membrane complex protein (omcB) gene, partial cds
12. DQ494813
Chlamydophila abortus strain POS large cysteine-rich 60 kDa membrane complex protein (omcB) gene, partial cds
13. DQ647677
Visna/Maedi virus strain 10-blood LTR, partial sequence
14. DQ647678
Visna/Maedi virus strain 10-brain LTR, partial sequence
15. DQ647679
Visna/Maedi virus strain 10-lung LTR, partial sequence
16. DQ647680
Visna/Maedi virus strain 10-udder LTR, partial sequence
17. DQ647681
Visna/Maedi virus strain 25-blood LTR, partial sequence
18. DQ647682
Visna/Maedi virus strain 25-brain LTR, partial sequence
19. DQ647683
Visna/Maedi virus strain 25-lung LTR, partial sequence
20. DQ647684
Visna/Maedi virus strain 25-udder LTR, partial sequence
21. DQ647685
Visna/Maedi virus strain 39-blood LTR, partial sequence
22. DQ647686
Visna/Maedi virus strain 39-lung LTR, partial sequence
23. DQ647687
Visna/Maedi virus strain 39-udder LTR, partial sequence
24. DQ647688
Visna/Maedi virus strain 85-blood LTR, partial sequence
25. DQ647689
Visna/Maedi virus strain 85-brain LTR, partial sequence
26. DQ647690
Visna/Maedi virus strain 85-lung LTR, partial sequence
27. DQ647691
Visna/Maedi virus strain 85-udder LTR, partial sequence
28. DQ647692
Visna/Maedi virus strain 93-brain LTR, partial sequence
29. DQ647693
Visna/Maedi virus strain 93-lung LTR, partial sequence
30. DQ647694
Visna/Maedi virus strain 93-udder LTR, partial sequence
31. DQ647695
Visna/Maedi virus strain 94-lung LTR, partial sequence
32. DQ647696
Visna/Maedi virus strain 94-udder LTR, partial sequence
33. DQ480645
Visna/Maedi virus strain MVV-4-lung LTR, partial sequence
34. DQ480646
Visna/Maedi virus strain MVV-4-liver LTR, partial sequence
35. DQ480647
Visna/Maedi virus strain MVV-4-heart LTR, partial sequence
36. DQ011532
Visna/Maedi virus strain 125-kidney LTR, partial sequence
37. DQ011533
Visna/Maedi virus strain 126-kidney LTR, partial sequence
38. DQ084441
Visna/Maedi virus strain MVV-Gr-LTR6 LTR, partial sequence
39. DQ084442
Visna/Maedi virus strain MVV-Gr-LTR7 LTR, partial sequence
40. DQ084443
Visna/Maedi virus strain MVV-Gr-LTR12 LTR, partial sequence
41. DQ084444
Visna/Maedi virus strain MVV-Gr-LTR19 LTR, partial sequence
42. DQ084445
Visna/Maedi virus strain MVV-Gr-LTR22 LTR, partial sequence
43. DQ084446
Visna/Maedi virus strain MVV-Gr-LTR58 LTR, partial sequence
44. DQ084447
Visna/Maedi virus strain MVV-Gr-LTR63 LTR, partial sequence
45. DQ084448
Visna/Maedi virus strain MVV-Gr-LTR80 LTR, partial sequence
46. DQ257291
Chlamydophila abortus strain FAG RNase P RNA subunit (rnpB) gene, partial sequence
47. DQ257292
Chlamydophila abortus strain LLG RNase P RNA subunit (rnpB) gene, partial sequence
48. DQ257293
Chlamydophila abortus strain POS RNase P RNA subunit (rnpB) gene, partial sequence
49. DQ257294
Chlamydophila abortus strain VPG RNase P RNA subunit (rnpB) gene, partial sequence
50. DQ257295
Chlamydophila abortus strain FAS RNase P RNA subunit (rnpB) gene, partial sequence
51. AY530289
Visna/Maedi virus strain SRLV-Greece-S1 25 kDa major core protein (gag) gene, partial cds
52. AY530290
Visna/Maedi virus strain SRLV-Greece-S2 25 kDa major core protein (gag) gene, partial cds
53. AY530291
Visna/Maedi virus strain SRLV-Greece-S3 25 kDa major core protein (gag) gene, partial cds
54. AY530292
Visna/Maedi virus strain SRLV-Greece-S4 25 kDa major core protein (gag) gene, partial cds
55. AY530293
Visna/Maedi virus strain SRLV-Greece-G1 25 kDa major core protein (gag) gene, partial cds
56. FJ825759
Canis lupus familiaris kallikrein-related peptidase 14 (KLK14) mRNA, complete cds, alternatively spliced
57. FJ825760
Canis lupus familiaris kallikrein-related peptidase 14 variant 1 (KLK14) mRNA, complete cds, alternatively spliced
58. FJ825761
Canis lupus familiaris kallikrein-related peptidase 14 variant 2 (KLK14) mRNA, complete cds, alternatively spliced
59. FJ825762
Canis lupus familiaris kallikrein-related peptidase 14 variant 3 (KLK14) mRNA, complete cds, alternatively spliced
60. FJ825763
Canis lupus familiaris kallikrein-related peptidase 14 variant 4 (KLK14) mRNA, complete cds, alternatively spliced
61. FJ825764
Canis lupus familiaris kallikrein-related peptidase 14 variant 5 (KLK14) mRNA, complete cds, alternatively spliced
62. EU126889
Canis lupus familiaris telomerase reverse transcriptase (TERT) mRNA, partial cds, alternatively spliced
63. EU126890
Canis lupus familiaris telomerase reverse transcriptase transcript variant 1 (TERT) mRNA, partial cds, alternatively spliced
64. EU126891
Canis lupus familiaris telomerase reverse transcriptase transcript variant 2 (TERT) mRNA, partial cds, alternatively spliced
65. EU126892
Canis lupus familiaris telomerase reverse transcriptase transcript variant 3 (TERT) mRNA, partial cds, alternatively spliced
66. EU126893
Canis lupus familiaris telomerase reverse transcriptase transcript variant 4 (TERT) mRNA, partial cds, alternatively spliced
67. EU126894
Canis lupus familiaris telomerase reverse transcriptase transcript variant 5 (TERT) mRNA, partial cds, alternatively spliced
68. EU563956
Cladosporium cladosporioides strain 4E 5.8S ribosomal RNA gene, partial sequence; internal transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequence
69. EU563957
Cladosporium cladosporioides strain 1N 5.8S ribosomal RNA gene, partial sequence; internal transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequence
70. GQ303574
Canis lupus familiaris kallikrein-related peptidase 9 (KLK9) mRNA, complete cds, alternatively spliced
71. GQ303575
Canis lupus familiaris kallikrein-related peptidase 9 variant 1 (KLK9) mRNA, complete cds, alternatively spliced
72. GQ303576
Canis lupus familiaris kallikrein-related peptidase 9 variant 2 (KLK9) mRNA, complete cds, alternatively spliced
73. GQ303577
Canis lupus familiaris kallikrein-related peptidase 9 variant 3 (KLK9) mRNA, complete cds, alternatively spliced
74. GQ303578
Canis lupus familiaris kallikrein-related peptidase 10 (KLK10) mRNA, complete cds
75. HM135452
Canis lupus familiaris kallikrein-related peptidase 4 precursor (KLK4) mRNA, complete cds
76. HM135453
Canis lupus familiaris kallikrein-related peptidase 5 precursor (KLK5) mRNA, complete cds
77. HM135454
Canis lupus familiaris kallikrein-related peptidase 6 precursor (KLK6) mRNA, complete cds
78. HM135455
Canis lupus familiaris kallikrein-related peptidase 7 precursor (KLK7) mRNA, complete cds
79. HM135456
Canis lupus familiaris kallikrein-related peptidase 8 precursor (KLK8) mRNA, complete cds, alternatively spliced
80. HM135457
Canis lupus familiaris kallikrein-related peptidase 8 variant 1 precursor (KLK8) mRNA, complete cds, alternatively spliced


favorites

Favorite websites

Here are some of my favorite websites that you can visit and find lots of useful info.